Insulin sensitivity and mitochondrial function are improved in children with burn injury during a randomized controlled trial of fenofibrate

Annals of Surgery

Volumn 245, Issue 2, 2007, Pages 214-221

  Cree, Melanie G ^a,b   Zwetsloot, Jennifer J ^e   Herndon, David N ^a,c   Qian, Ting ^b   Morio, Beatrice ^d   Fram, Ricki ^a,c   Sanford, Arthur P ^a,c   Aarsland, Asle ^a,c   Wolfe, Robert R ^a,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c SHRINERS HOSPITALS FOR CHILDREN   (United States)

^d CRNH AUVERGNE   (France)

^e EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CITRATE SYNTHASE; CYTOCHROME C OXIDASE; FENOFIBRATE; GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PLACEBO; PYRUVIC ACID; TYROSINE;

ADOLESCENT; ARTICLE; BODY SURFACE; BURN; CHILD; CLAMP; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HORMONAL REGULATION; HUMAN; HYPERINSULINEMIC EUGLYCEMIC CLAMP; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; LABORATORY TEST; MITOCHONDRIAL RESPIRATION; MUSCLE BIOPSY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN PHOSPHORYLATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

ADOLESCENT; ANTILIPEMIC AGENTS; BIOPSY; BLOOD GLUCOSE; BURNS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; LIVER; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; PPAR ALPHA; PROCETOFEN; PROSPECTIVE STUDIES; TRAUMA SEVERITY INDICES; TREATMENT OUTCOME;

EID: 33846465014     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000250409.51289.ca     Document Type: Article

References (42)

1. Howard JM. Studies of the absorption and metabolism of glucose following injury: the systemic response to injury. Ann Surg. 1955;141: 321-326.
2. Wolfe RR. Glucose metabolism in burn injury: a review. J Burn Care Rehabil. 1985;6:408-418.
3. Thorell A, Efendic S, Gutniak M, et al. Insulin resistance after abdominal surgery. Br J Surg. 1994;81:59-63.
4. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-1367.
5. Gore DC, Chinkes D, Heggers J, et al. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma. 2001;51:540-544.
6. Qian T, Cree M, Aarsland A, et al. Fenofibrate improves muscle mitochondrial oxidative capacity after burn trauma. FASEB J. 2005;19:A565.
7. Padfield KE, Astrakas LG, Zhang Q, et al. Burn injury causes mitochondrial dysfunction in skeletal muscle. Proc Natl Acad Sci USA. 2005;102:5368-5373.
8. Yasuhara S, Perez ME, Kanakubo E, et al. Skeletal muscle apoptosis after burns is associated with activation of proapoptotic signals. Am J Physiol Endocrinol Metab. 2000;279:E1114-E1121.
9. Wang XM, Chen KM, Wang Y, et al. Functional changes in rat-liver mitochondria during the early phase of burn injury. Burns Incl Therm Inj. 1986;12:461-464.
10. Vanhorebeek I, De Vos R, Mesotten D, et al. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet. 2005;365:53-59.
11. Shulman GI. Unraveling the cellular mechanism of insulin resistance in humans: new insights from magnetic resonance spectroscopy. Physiology (Bethesda). 2004;19:183-190.
12. Kelley DE, He J, Menshikova EV, et al. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002;51:2944-2950.
13. Gore DC, Wolf SE, Herndon DN, et al. Metformin blunts stress-induced hyperglycemia after thermal injury. J Trauma. 2003;54:555-561.
14. Rangwala SM, Lazar MA. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. Trends Pharmacol Sci. 2004;25:331-336.
15. Herndon DN, Tompkins RG. Support of the metabolic response to burn injury. Lancet. 2004;363:1895-1902.
16. Furuhashi M, Ura N, Murakami H, et al. Fenofibrate improves insulin sensitivity in connection with intramuscular lipid content, muscle fatty acid-binding protein, and beta-oxidation in skeletal muscle. J Endocrinol. 2002;174:321-329.
17. Minnich A, Tian N, Byan L, et al. A potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle. Am J Physiol Endocrinol Metab. 2001;280:E270-E279.
18. Jonkers IJ, Mohrschladt MF, Westendorp RG, et al. Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial. Am J Med. 2002;112:275-280.
19. Pereira C, Murphy K, Jeschke M, et al. Post burn muscle wasting and the effects of treatments. Int J Biochem Cell Biol. 2005;37:1948-1961.
20. Wolfe R, Chinkes D. Isotope Tracers in Metabolic Research, 2nd ed. New York: Wiley-Liss, 2005.
21. Morio B, Hocquette JF, Montaurier C, et al. Muscle fatty acid oxidative capacity is a determinant of whole body fat oxidation in elderly people. Am J Physiol Endocrinol Metab. 2001;280:E143-E149.
22. Chance B, Williams GR. The respiratory chain and oxidative phosphorylation. Adv Enzymol Relat Subj Biochem. 1956;17:65-134.
23. Veksler VI, Kuznetsov AV, Sharov VG, et al. Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment by using saponin-skinned fibers. Biochim Biophys Acta. 1987;892:191-196.
24. Alp PR, Newsholme EA, Zammit VA. Activities of citrate synthase and NAD -linked and NADP -linked isocitrate dehydrogenase in muscle from vertebrates and invertebrates. Biochem J. 1976;154:689-700.
25. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
26. Zhou Q, Dolan PL, Dohm GL. Dephosphorylation increases insulinstimulated receptor kinase activity in skeletal muscle of obese Zucker rats. Mol Cell Biochem. 1999;194:209-216.
27. Damci T, Tatliagac S, Osar Z, et al. Fenofibrate treatment is associated with better glycemic control and lower serum leptin and insulin levels in type 2 diabetic patients with hypertriglyceridemia. Eur J Intern Med. 2003;14:357-360.
28. Weiss R, Dufour S, Taksali SE, et al. Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet. 2003;362:951-957.
29. Veening MA, Van Weissenbruch MM, Delemarre-Van De Waal HA. Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. J Clin Endocrinol Metab. 2002;87:4657-4661.
30. Wolfe RR, Durkot MJ, Allsop JR, et al. Glucose metabolism in severely burned patients. Metabolism. 1979;28:1031-1039.
31. Shalitin S, Abrahami M, Lilos P, et al. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiarycare center in Israel. Int J Obes (Lond). 2005;29:571-578.
32. Weiss R, Dufour S, Groszmann A, et al. Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation. J Clin Endocrinol Metab. 2003;88:2014-2018.
33. Black PR, Brooks DC, Bessey PQ, et al. Mechanisms of insulin resistance following injury. Ann Surg. 1982;196:420-435.
34. Crabb DW, Galli A, Fischer M, et al. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha. Alcohol. 2004;34:35-38.
35. Ikezu T, Okamoto T, Yonezawa K, et al. Analysis of thermal injury-induced insulin resistance in rodents: implication of postreceptor mechanisms. J Biol Chem. 1997;272:25289-25295.
36. Zhang Q, Carter EA, Ma BY, et al. Molecular mechanism(s) of burn-induced insulin resistance in murine skeletal muscle: role of IRS phosphorylation. Life Sci. 2005;77:3068-3077.
37. Goodyear LJ, Giorgino F, Sherman LA, et al. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest. 1995;95:2195-2204.
38. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science. 2005;307:384-387.
39. Wolfe RR, Jahoor F, Herndon DN, et al. Isotopic evaluation of the metabolism of pyruvate and related substrates in normal adult volunteers and severely burned children: effect of dichloroacetate and glucose infusion. Surgery. 1991;110:54-67.
40. MacLellan JD, Gerrits MF, Gowing A, et al. Physiological increases in uncoupling protein 3 augment fatty acid oxidation and decrease reactive oxygen species production without uncoupling respiration in muscle cells. Diabetes. 2005;54:2343-2350.
41. Li YP, Atkins CM, Sweatt JD, et al. Mitochondria mediate tumor necrosis factor-alpha/NF-kappaB signaling in skeletal muscle myotubes. Antioxid Redox Signal. 1999;1:97-104.
42. Kim JK, Fillmore JJ, Sunshine MJ, et al. PKC-theta knockout mice are protected from fat-induced insulin resistance. J Clin Invest. 2004;114: 823-827.